Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

41 ArticlesBuyBack

1 / 5

Experimentals: A Great Beginning to 2021 with TCS, Majesco and Wipro

We've had some very interesting experimentals in 2020, and we have a great start in 2021 in closing three experimentals with a reasonable profit, in the first ...
DHFL-scaled.jpg

TCS: Deep Inside its Buyback is a Tax-Efficient Dividend

You have to love buybacks. A company buys back its own shares, and you’re thinking: Wow, they also like their share price! You are being naive, brother. ...
Featured-Image-4.jpg

Will Holding Companies Buy Back Shares or Give Dividends Now?

Budget 2020 said dividends will be taxed after April 2020. One particular set of companies deserves a deeper look. Holding Companies. Note: Thanks to alert ...
Holding-Companies.jpg

Premium: The Indiabulls Housing Saga, and Funds that Own Indiabulls Housing Finance Bonds

A lot has been happening with Indiabulls Housing Finance. With Prashant Bhushan filing a PIL against Indiabulls Housing Finance, and the RBI cancelling its ...
ibulss.jpg

Why Buybacks Are Still Going To Be Attractive

Budget 2019 introduced a change in the rules for buybacks. Any buyback of shares of a company gets taxed at 20% if it’s done after the budget date, i.e. ...
buybacks.jpg

Bond Baba: A Quick Look at Buybacks – MPhasis, Tata Investments, Bosch and SKF

Bond Baba has been looking at various buybacks, and while we haven’t participated in any officially, we’d like to make a quick list of buybacks ...
Premium-Image.png

A Credit Report on Blackstone’s Bonds Reveals Something Interesting about the Mphasis buyback

On our experimental and corp-actions-and-ipo channel at Capitalmind Premium, we recently had an interesting discussion on the buyback announced by Mphasis. ...
mphasis-buyback.png

Buybacks Go Sour. But It Gives Us A New Idea For The Long-Term

We now recognize that buybacks are crowded trades and will not pursue them as a strategy or a special opportunity, except where the stock itself looks good ...
capital-mind-premium-featured-image.png

Premium: Bond Baba Regrets a Failed Buyback From Overambitious Entry

While the buybacks we've targeted have done well so far, the last one was a failed attempt, and we'll ...
capital-mind-premium-featured-image.png

Bond Baba: Is Unichem Buyback Worth a Peck?

Unichem - A specialty pharmaceutical company, specialized in niche therapy areas of cardiology, neurology, orthopedics and anti-infective. Unichem has recently ...
capital-mind-premium-featured-image.png